According to our (Global Info Research) latest study, the global Biological Specimen Preservation & Handling market size was valued at US$ 5762 million in 2025 and is forecast to a readjusted size of US$ 10073 million by 2032 with a CAGR of 8.2% during review period.
Biological sample storage and processing services refer to third-party services that manage human, animal, or microbial samples, providing end-to-end or modular workflows including sample receipt, identification registration, barcode tracking, pre-processing, aliquoting, refrigerated/frozen/ultra-low temperature/liquid nitrogen storage, inventory management, inbound and outbound logistics, transport, and eventual disposal. Essentially, these services constitute “sample asset management plus cold chain compliant operations.” The overall gross margin is approximately 48%.
The core demand for biological sample storage and processing comes from drug development, clinical trials, diagnostic development, and advanced therapies. Pharmaceutical companies and CROs increasingly outsource biobanking, cold chain management, sample logistics, and tracking to professional institutions, as any loss, uncontrolled freeze-thaw, or incomplete chain-of-custody records can directly impact clinical data quality and regulatory compliance.
Industry growth is driven not simply by an increase in sample quantity but by higher sample value. With the rise of oncology, immunology, rare diseases, companion diagnostics, cell therapies, and gene therapies, requirements for PBMCs, cells, tissues, RNA, viral vectors, and therapeutic-grade retained samples in terms of temperature zones, timing, viability, and traceability have significantly increased. The competitive landscape is concentrating around “global network + compliance capability + data systems.” Lower-end frozen storage faces regional competition and price pressure, while liquid nitrogen storage, GxP/GMP compliance, cell therapy, multinational clinical trial sample management, and high-value sample transfers remain high-barrier segments.
Over the next six years, the market is expected to grow from USD 6.1 billion in 2026 to USD 9.1 billion by 2031, driven primarily by more complex clinical trials, the industrialization of advanced therapies, digital sample management, and pharmaceutical outsourcing for cost reduction. Overall, this is a moderately sized professional life sciences service market with high client stickiness, strong compliance barriers, and stable gross margins.
This report is a detailed and comprehensive analysis for global Biological Specimen Preservation & Handling market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Biological Specimen Preservation & Handling market size and forecasts, in consumption value ($ Million), 2021-2032
Global Biological Specimen Preservation & Handling market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Biological Specimen Preservation & Handling market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Biological Specimen Preservation & Handling market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biological Specimen Preservation & Handling
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biological Specimen Preservation & Handling market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azenta Life Sciences, Thermo Fisher Scientific / Patheon / PPD, Labcorp, IQVIA Laboratories, ICON plc, Medpace, Precision for Medicine, Cryoport Systems, SciSafe, Masy BioServices, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Biological Specimen Preservation & Handling market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Storage Only
Sample Processing
Inventory Management
Logistics Management
Full Service
Other Services
Market segment by Storage Condition
Controlled Ambient
Refrigerated
Frozen
Ultra-Low
Cryogenic
Special Conditions
Market segment by Specimen Form
Fluid Specimens
Analytical Tissue Specimens
Cell Specimens
Molecular Specimens
Microbial Specimens
Gross Anatomical Specimens
Other Specimens
Market segment by Application
Drug R&D
Diagnostics
Medical Training
Others
Market segment by players, this report covers
Azenta Life Sciences
Thermo Fisher Scientific / Patheon / PPD
Labcorp
IQVIA Laboratories
ICON plc
Medpace
Precision for Medicine
Cryoport Systems
SciSafe
Masy BioServices
Sampled
Eurofins Viracor BioPharma
Cerba Research
Clinigen
Almac Group
CellCarta
Frontage Laboratories
LabConnect
KCAS Bio
Quest Diagnostics
Charles River Laboratories
WuXi AppTec
Parexel
Sonic Clinical Trials
REPROCELL
Astoriom
Cryosite
Discovery Life Sciences
BioIVT
Boca Biolistics
Cureline
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Biological Specimen Preservation & Handling product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biological Specimen Preservation & Handling, with revenue, gross margin, and global market share of Biological Specimen Preservation & Handling from 2021 to 2026.
Chapter 3, the Biological Specimen Preservation & Handling competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Biological Specimen Preservation & Handling market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Biological Specimen Preservation & Handling.
Chapter 13, to describe Biological Specimen Preservation & Handling research findings and conclusion.
Summary:
Get latest Market Research Reports on Biological Specimen Preservation & Handling. Industry analysis & Market Report on Biological Specimen Preservation & Handling is a syndicated market report, published as Global Biological Specimen Preservation & Handling Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Biological Specimen Preservation & Handling market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.